Delfini Group is a public service entrepreneurship founded to advance applied evidence- and value-based clinical quality improvements through practice, training and facilitation. Much of Delfini's work is dedicated to solving medical misinformation problems. Delfini has contributed to text books, advised government entities, worked with health care systems, payers and manufacturers and has trained thousands in evidence-based quality improvement.
Michael E. Stuart MD & Sheri Ann Strite are medical information scientists, evidologists and clinical improvement experts who combine academic and practical experience to train people how to evaluate medical research studies, conduct evidence reviews, help health care systems apply evidence- and value-based clinical quality improvement methods including special help for work groups such as clinical guideline development teams, pharmacy & therapeutics and medical technology assessment committees, clinical quality improvement teams and more. They also train physicians and others in communicating with patients.
Sheri Ann Strite, Co-founder, Principal & Managing Partner, initiated many Delfini health care improvement strategies, tools and training programs including the popular Delfini critical appraisal training program. Formerly she was Associate Director, Program Development, University of California, San Diego (UCSD) Family & Preventive Medicine, School of Medicine, where she taught faculty, physicians, residents, students and others. She was also a member of the UCSD Family Medicine Research Leaders and faculty for their Research Fellowship in the Department of Family & Preventive Medicine. Prior to UCSD, Ms. Strite worked in clinical improvement, education and research at Group Health Cooperative in Seattle, Washington, where she held various positions.
Michael E. Stuart MD, Co-founder, President & Medical Director, is a family physician and was appointed clinical faculty at the University of Washington in 1975. He is the former Director of the Department of Clinical Improvement and Education at Group Health Cooperative in Seattle, Washington, where he led development of more than 35 evidence-based clinical guidelines and other clinical improvements, chaired the Pharmacy & Therapeutics and Medical Technology Assessment Committees. His work has received praise from prominent health care leaders such as David Eddy MD, Don Berwick MD, Health Ministry of New Zealand and the US Navy.